Toll-like receptor agonists as adjuvants for HIV vaccines

Current Medicinal Chemistry

Volumn 18, Issue 33, 2011, Pages 5079-5082

  Stevceva, L ^a  

^a GOCE DELCEV UNIVERSITY   (Macedonia)

Author keywords

B cells; DCs; HIV; T cells; TLRs

Indexed keywords

BACTERIAL DNA; BACTERIUM LIPOPROTEIN; DOUBLE STRANDED RNA; FLAGELLIN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOPROTEIN; LIPOTEICHOIC ACID; NEF PROTEIN; POL PROTEIN; REV PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR AGONIST; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; CPG ISLAND; DENDRITIC CELL; DISEASE COURSE; DRUG BINDING; GENETIC POLYMORPHISM; HUMAN; INNATE IMMUNITY; MICROORGANISM DETECTION; NONHUMAN; RECEPTOR UPREGULATION; TOXOPLASMA GONDII; VIRUS LOAD;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; B-LYMPHOCYTES; DENDRITIC CELLS; HIV; HUMANS; MICE; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 80054860177     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797636027     Document Type: Article

References (54)

1. Medzhitov, R. Toll-like receptors and innate immunity, Nat Rev Immunol, 2001, 1(2), 135-45. (Pubitemid 33741967)
2. Iwasaki, A. and R. Medzhitov. Toll-like receptor control of the adaptive immune responses, Nat Immunol, 2004, 5(10), 987-95. (Pubitemid 41057715)
3. Hashimoto, C., K.L. Hudson, and K.V. Anderson. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein, Cell, 1988, 52(2), 269-79.
4. Kawai, T. and S. Akira. The roles of TLRs, RLRs and NLRs in pathogen recognition, Int Immunol, 2009, 21(4), 317-37.
5. Manicassamy, S. and B. Pulendran. Modulation of adaptive immunity with Toll-like receptors, Semin Immunol, 2009, 21(4), 185-93.
6. Janeway, C.A., Jr. and R. Medzhitov. Innate immune recognition, Annu Rev Immunol, 2002, 20 197-216. (Pubitemid 34293424)
7. Alexopoulou, L., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3, Nature, 2001, 413(6857), 732-8. (Pubitemid 33009951)
8. Takeuchi, O., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components, Immunity, 1999, 11(4), 443-51. (Pubitemid 29504199)
9. Schwandner, R., et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2, J Biol Chem, 1999, 274(25), 17406-9.
10. Hayashi, F., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, 2001, 410(6832), 1099-103. (Pubitemid 32391041)
11. Hemmi, H., et al. A Toll-like receptor recognizes bacterial DNA, Nature, 2000, 408(6813), 740-5. (Pubitemid 32015992)
12. Hacker, H., et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation, Embo J, 1998, 17(21), 6230-40. (Pubitemid 28497796)
13. Heil, F., et al. Species-specific recognition of single-stranded RNA via tolllike receptor 7 and 8, Science, 2004, 303(5663), 1526-9. (Pubitemid 38314424)
14. Yarovinsky, F., et al. TLR11 activation of dendritic cells by a protozoan profillin-like protein, Science, 2005, 308(5728), 1626-9. (Pubitemid 40807512)
15. Thoma-Uszynski, S., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors, Science, 2001, 291(5508), 1544-7. (Pubitemid 32179220)
16. Cao, W. and Y.J. Liu. Innate immune functions of plasmacytoid dendritic cells, Curr Opin Immunol, 2007, 19(1), 24-30. (Pubitemid 46073695)
17. Honda, K., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction, Nature, 2005, 434(7036), 1035-40. (Pubitemid 40586053)
18. Agrawal, S., et al. Cutting edge: Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c- Fos, J Immunol, 2003, 171(10), 4984-9. (Pubitemid 37432777)
19. Schwarz, K., et al. Role of Toll-like receptors in costimulating cytotoxic T cell responses, Eur J Immunol, 2003, 33(6), 1465-70. (Pubitemid 36790406)
20. Datta, S.K., et al. A subset of Toll-like receptor ligands induces crosspresentation by bone marrow-derived dendritic cells, J Immunol, 2003, 170(8), 4102-10. (Pubitemid 36428173)
21. Le Bon, A., et al. Cross-priming of CD8+ T cells stimulated by virusinduced type I interferon, Nat Immunol, 2003, 4(10), 1009-15. (Pubitemid 37265922)
22. Pulendran, B. Modulating vaccine responses with dendritic cells and Tolllike receptors, Immunol Rev, 2004, 199 227-50. (Pubitemid 38736775)
23. Hornung, V., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J Immunol, 2002, 168(9), 4531-7. (Pubitemid 34441357)
24. Zarember, K.A. and P.J. Godowski. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines, J Immunol, 2002, 168(2), 554-61. (Pubitemid 34049553)
25. Komai-Koma, M., et al. TLR2 is expressed on activated T cells as a costimulatory receptor, Proc Natl Acad Sci U S A, 2004, 101(9), 3029-34. (Pubitemid 38327729)
26. Caron, G., et al. Direct stimulation of human T cells via TLR5 and TLR7/8: Flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells, J Immunol, 2005, 175(3), 1551-7. (Pubitemid 41023056)
27. Babu, S., et al. Cutting edge: Diminished T cell TLR expression and function modulates the immune response in human filarial infection, J Immunol, 2006, 176(7), 3885-9. (Pubitemid 44264362)
28. Gururajan, M., J. Jacob, and B. Pulendran. Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets, PLoS One, 2007, 2(9), e863.
29. Bernasconi, N.L., N. Onai, and A. Lanzavecchia. A role for Toll-like receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells, Blood, 2003, 101(11), 4500-4. (Pubitemid 36857820)
30. Bekeredjian-Ding, I.B., et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN, J Immunol, 2005, 174(7), 4043-50.
31. Mansson, A., et al. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation, Immunology, 2006, 118(4), 539-48. (Pubitemid 44079572)
32. Blaas, S.H., et al. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells, Clin Exp Immunol, 2009, 155(3), 534-40.
33. Cognasse, F., et al. Differential production of immunoglobulin classes and subclasses by mucosal-type human B-lymphocytes exposed in vitro to CpG oligodeoxynucleotides, Clin Chem Lab Med, 2005, 43(1), 22-31. (Pubitemid 40287496)
34. Peng, S.L. Signaling in B cells via Toll-like receptors, Curr Opin Immunol, 2005, 17(3), 230-6. (Pubitemid 40692656)
35. Jegerlehner, A., et al. TLR9 signaling in B cells determines class switch recombination to IgG2a, J Immunol, 2007, 178(4), 2415-20. (Pubitemid 46233441)
36. Hayashi, E.A., S. Akira, and A. Nobrega. Role of TLR in B cell development: Signaling through TLR4 promotes B cell maturation and is inhibited by TLR2, J Immunol, 2005, 174(11), 6639-47. (Pubitemid 40705624)
37. Dorner, M., et al. Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production, Immunology, 2009, 128(4), 573-9.
38. Bochud, P.Y., et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection, Aids, 2007, 21(4), 441-6.
39. Ricci, E., et al. Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1, J Transl Med, 8 49.
40. Pine, S.O., M.J. McElrath, and P.Y. Bochud. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals, Aids, 2009, 23(18), 2387-95.
41. Oh, D.Y., et al. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression, Aids, 2009, 23(3), 297-307.
42. Oh, D.Y., et al. A functional toll-like receptor 8 variant is associated with HIV disease restriction, J Infect Dis, 2008, 198(5), 701-9.
43. Trumpfheller, C., et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine, Proc Natl Acad Sci U S A, 2008, 105(7), 2574-9. (Pubitemid 351520555)
44. Grossmann, C., et al. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands, BMC Immunol, 2009, 10 43.
45. Wille-Reece, U., et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates, Proc Natl Acad Sci U S A, 2005, 102(42), 15190-4. (Pubitemid 41513357)
46. Kwissa, M., et al. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus, J Exp Med, 2007, 204(11), 2733-46. (Pubitemid 350044795)
47. Becker, P.D., et al. The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant, Vaccine, 2006, 24(25), 5269-76. (Pubitemid 43818200)
48. Appledorn, D.M., et al. A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target, PLoS One, 5(3), e9579.
49. Appledorn, D.M., et al. Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 immunity, Clin Vaccine Immunol, 18(1), 150-60.
50. Sui, Y., et al. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques, Proc Natl Acad Sci U S A, 107(21), 9843-8.
51. Hoebe, K., et al. CD36 is a sensor of diacylglycerides, Nature, 2005, 433(7025), 523-7. (Pubitemid 40204309)
52. Chuang, T. and R.J. Ulevitch. Identification of hTLR10: A novel human Tolllike receptor preferentially expressed in immune cells, Biochim Biophys Acta, 2001, 1518(1-2), 157-61. (Pubitemid 32232289)
53. Zhang, D., et al. A toll-like receptor that prevents infection by uropathogenic bacteria, Science, 2004, 303(5663), 1522-6. (Pubitemid 38314423)
54. Shi, Z., et al. A novel Toll-like receptor that recognizes vesicular stomatitis virus, J Biol Chem, 286(6), 4517-24.